Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Apr 21, 2026 12:10 PM ・ Updated Jun 2, 2026 1:02 PM ・ 2 min read ・ Source: PR TIMES
Aylat Inc., a Japanese radiation therapy AI startup, has commenced international joint research on "AIVOT," a proton beam therapy AI aimed at reducing the burden on medical professionals and improving patient outcomes.
Aylat Inc., a radiation therapy AI startup originating from Japan, is actively engaged in the research and development of "AIVOT," a radiation therapy AI truly essential for clinical medical settings. By utilizing AIVOT, we aim to alleviate the workload of medical professionals, increase the number of patients who can receive high-precision radiation therapy, and ultimately enhance treatment outcomes.
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.